Page last updated: 2024-09-02

cinnabarinic acid and Disease Models, Animal

cinnabarinic acid has been researched along with Disease Models, Animal in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Antenucci, N; Battaglia, G; Bruno, V; Chocyk, A; Cieslik, P; Curto, M; Di Menna, L; Fazio, F; Fucile, S; Giannino, G; Iacovelli, L; Liberatore, F; Lionetto, L; Martinello, K; Mascio, G; Nicoletti, F; Pilc, A; Pittaluga, A; Simmaco, M; Traficante, A; Ulivieri, M; Vergassola, M; Wierońska, JM	1
Allegrucci, M; Belladonna, ML; Bessede, A; Busceti, C; Fallarino, F; Fazio, F; Gargaro, M; Lionetto, L; Nicoletti, F; Notartomaso, S; Scarselli, P; Simmaco, M; Vacca, C; Volpi, C; Zappulla, C	1

Other Studies

2 other study(ies) available for cinnabarinic acid and Disease Models, Animal

Article	Year
The Trace Kynurenine, Cinnabarinic Acid, Displays Potent Antipsychotic-Like Activity in Mice and Its Levels Are Reduced in the Prefrontal Cortex of Individuals Affected by Schizophrenia. Schizophrenia bulletin, 2020, 12-01, Volume: 46, Issue:6 Topics: Adult; Animals; Antipsychotic Agents; Behavior, Animal; Cells, Cultured; Disease Models, Animal; Electrophysiological Phenomena; Female; Humans; Kynurenine; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Middle Aged; Oxazines; Prefrontal Cortex; Rats; Rats, Wistar; Receptors, Metabotropic Glutamate; Schizophrenia; Tissue Banks	2020
Cinnabarinic acid, an endogenous agonist of type-4 metabotropic glutamate receptor, suppresses experimental autoimmune encephalomyelitis in mice. Neuropharmacology, 2014, Volume: 81 Topics: Animals; Benzopyrans; Central Nervous System; Cytokines; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Excitatory Amino Acid Agonists; Male; Mice; Mice, Inbred C57BL; Myelin Basic Protein; Myelin-Oligodendrocyte Glycoprotein; Myosin Type II; Nuclear Receptor Subfamily 1, Group F, Member 3; Oxazines; Peptide Fragments; Receptors, Metabotropic Glutamate; T-Box Domain Proteins; Th17 Cells; Time Factors; Transcription Factors	2014

Article

Year

The Trace Kynurenine, Cinnabarinic Acid, Displays Potent Antipsychotic-Like Activity in Mice and Its Levels Are Reduced in the Prefrontal Cortex of Individuals Affected by Schizophrenia.

Schizophrenia bulletin, 2020, 12-01, Volume: 46, Issue:6

Topics: Adult; Animals; Antipsychotic Agents; Behavior, Animal; Cells, Cultured; Disease Models, Animal; Electrophysiological Phenomena; Female; Humans; Kynurenine; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Middle Aged; Oxazines; Prefrontal Cortex; Rats; Rats, Wistar; Receptors, Metabotropic Glutamate; Schizophrenia; Tissue Banks

2020

Cinnabarinic acid, an endogenous agonist of type-4 metabotropic glutamate receptor, suppresses experimental autoimmune encephalomyelitis in mice.

Neuropharmacology, 2014, Volume: 81

Topics: Animals; Benzopyrans; Central Nervous System; Cytokines; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Excitatory Amino Acid Agonists; Male; Mice; Mice, Inbred C57BL; Myelin Basic Protein; Myelin-Oligodendrocyte Glycoprotein; Myosin Type II; Nuclear Receptor Subfamily 1, Group F, Member 3; Oxazines; Peptide Fragments; Receptors, Metabotropic Glutamate; T-Box Domain Proteins; Th17 Cells; Time Factors; Transcription Factors

2014